Comment on "Role of vasopressin in the management of septic shock" by Mutlu and Factor.
Martin W
MW
Dünser
Andreas J
AJ
Mayr
Volker
V
Wenzel
Walter R
WR
Hasibeder
D001127:Arginine Vasopressin / Q000378:metabolism / Q000627:therapeutic use; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D008236:Lypressin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011652:Pulmonary Circulation / Q000187:drug effects; D012772:Shock, Septic / Q000188:drug therapy* / Q000378:metabolism; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014667:Vasopressins / Q000378:metabolism / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D014667:Vasopressins; D001127:Arginine Vasopressin; D008236:Lypressin